Results 111 to 120 of about 27,017 (217)

Deciphering the Role of V88L Substitution in NDM-24 Metallo-β-Lactamase

, 2019
The New Delhi metallo-β-lactamase-1 (NDM-1) is a typical carbapenemase and plays a crucial role in antibiotic-resistance bacterial infection. Phylogenetic analysis, performed on known NDM-variants, classified NDM enzymes in seven clusters.
Zhihai Liu, Wan Li, Alessandra Piccirilli, Dejun Liu, Jianzhong Shen, Yang Wang   +5 more
core   +1 more source

Genetic characterisation of NDM-1 and NDM-5-producing Enterobacterales from retail chicken meat in Egypt [PDF]

Journal of Global Antimicrobial Resistance, 2020
Sadek, M., Poirel, L., Nordmann, P., Nariya, H., Shimamoto, T., Shimamoto, T.   +5 more
openaire   +5 more sources

Development and validation of a lateral flow immunoassay for rapid detection of NDM-producing Enterobacteriaceae

, 2017
The global spread of carbapenemase-producing Enterobacteriaceae (CPE) that are often resistant to most, if not all, classes of antibiotics is a major public health concern.
Boutal, Hervé, Devilliers, Karine, Oueslati, Saoussen, Saoussen Oueslati, Stéphanie Simon, Hervé Volland, Laurent Dortet, Dortet, Laurent, Hervé Boutal, Naas, Thierry, Bernabeu, Sandrine, Karine Devilliers, Sandrine Bernabeu, Volland, Hervé, Simon, Stéphanie, Thierry Naas   +15 more
core   +1 more source

NDM arrived to Republic of Georgia [PDF]

Journal of Global Antimicrobial Resistance, 2017
T. Koiava, D. Gonçalves, J. Palmeira, K. Arobelidze, M. Tediashvili, L. Akhvlediani, H. Ferreira   +6 more
openaire   +1 more source

Structural role of K224 in taniborbactam inhibition of NDM-1

Taniborbactam (TAN; VNRX-5133) is a novel bicyclic boronic acid β-lactamase inhibitor (BLI) being developed in combination with cefepime (FEP). TAN inhibits both serine and some metallo-β-lactamases. Previously, the substitution R228L in VIM-24 was shown
Vila, Alejandro J., Vila, Alejandro Jose, Mojica, Maria F., Ono, Daisuke, Ishii, Yoshikazu, Bonomo, Robert A., Bethel, Christopher R., Drusin, Salvador I., Moreno, Diego M., Moreno, Diego Martin, Drusin, Salvador Iván   +10 more
core   +1 more source

Carbapenem-resistant Pseudomonas aeruginosa producing NDM-1

Publicado originalmente em: JORGE, Paulo Ricardo Freitag; et. al. Pseudomonas aeruginosa resistente aos carbapenêmicos produtor de NDM-1. Revista Médica de Minas Gerais, [S.L.], v. 33, p. 1-5, fev. 2023. GN1 Sistemas e Publicacoes Ltd.. http://dx.doi.org/
Pimenta, João Paulo, Brito, Cristiane Silveira de, Jorge, Paulo Ricardo Freitag, Gontijo Filho, Paulo Pinto   +3 more
core   +1 more source

Molecular Characterization of a KPC-2- and NDM-1-Producing Klebsiella michiganensis Clinical Isolate in Cerebrospinal Fluid

Infection and Drug Resistance
Mingyue Sun, Weiqiang Xiao, Qingxia Xu Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, People’s Republic of ChinaCorrespondence: Qingxia Xu, Department of Clinical ...
Sun M, Xiao W, Xu Q
doaj  

Genetic basis of transmission of bla NDM-1 among foodborne Vibrio parahaemolyticus strains in China

Applied Microbiology and Biotechnology
Carbapenem-resistant Vibrio parahaemolyticus has emerged and spread extensively in China, posing a substantial threat to food safety and human health. This study investigated the prevalence of carbapenem resistance in V.
Dan Chen, Ruanyang Sun, Jing Wang, Kaichao Chen, Miaomiao Xie, Qinlu Lin, Jinwang Li, Sheng Chen, Xiaobo Liu   +8 more
doaj   +1 more source

Clinical and molecular characterization of NDM-9 and NDM-13 producing multidrug-resistant Escherichia coli strains in China

BMC Microbiology
Objectives The continuous evolution of NDM variants, some of which exhibit enhanced hydrolytic activity, poses a serious public health threat and necessitates ongoing surveillance.
Jia Tao, Gang Li, Zhichen Zhu, Jie Zhu, Wen Wang, Hui Fu, Hua Yv, Bin Shan, Liru Wang, Yiwei Tang, Liang Chen, Hong Du, Wei Jia   +12 more
doaj   +1 more source

Combating New Delhi metallo-beta-lactamase-1 (NDM-1): an integrated review of inhibitor development and next-generation therapeutic platforms. [PDF]

RSC Adv
Mohanty A, Sahoo RK, Sanket AS, Rout E.
europepmc   +1 more source